Wilsede synapses cooperation
Human Leukemia
The leukemic cell has a normal blood cell counterpart.
The exact reason why the normal blood cell differentation is blocked and becomes an leukemic cell is since Virchow, 150 years ago, unknown.
Multiple factors are involved in the etiology of leukemia and cancer.
Exchange and coordination between clinicians, immunologists, molecular biologists, genetists and virologists will help a better understanding of the biology of leukemia translated into improved methods of treatment.
For this we joined IACRLRD, Leukemia-Net, Acute-Leukemia, Wilsede and started the Portal www.humanleukemia.com to help in leukemia diagnosis and therapy worldwide.
To keep this idea alive we need the academic help of our scientific friends arround the world and personal support of all willing to help leukemia patients.
Science Connections
The Wilsede Meetings "Modern Trends in Human Leukemia" started June 1973 in a 350 year old farmhouse "De Emhoff" in Wilsede.
The idea to bring together highly qualified biochemists, medical doctors, and virologists to learn, like students, about each other's fields has been very unusual. But to understand human leukemia, the virologists and biochemists have to learn more about the properties of the human blood cell, and the medical doctors have to learn where and how leukemic misinformation can influence the normal regulation of the molecular control mechanism in a blood cell
Memories and inspirations of more than 1000 Wilsede participants, among them scientists like Tim Hunt, Bob Gallo, Harald zur Hausen, Mel Greaves, Don Pinkel or Karl Welte are documented in science-connections.com to inform and interest the coming generations of young scientists in school and university.
We are supported in terms of both personal, academic information and at a modest level financially.
IACRLRD (International Association for Comparative Research on Leukemia and Related Diseases)
The aspect of comparative research on leukemia and related diseases led, in 1960, the world health organization to inaugurate the International Association and its symposia to take place at various sites around the world every two years. The comparative aspect brings together physicians, veterinarians and scientists in basic research to promote research and to improve outcome in leukemia and related diseases worldwide.
ACUTE LEUKEMIAS XIV Biology and Treatment Strategies
The next biennial symposium ACUTE LEUKEMIAS will be held in Munich February 24 to February 27, 2013.
This event will offer again invaluable benefits for all attendees, including the opportunity to discuss the most recent findings in basic research and latest results of clinical studies with international experts in these fields, thus providing the opportunity to become updated on recent developments in the complex field of leukemia research and therapy.
Moreover, the meeting offers many networking events that will allow you to connect with colleagues and interact with leaders in the field of leukemia research and to learn and share your ideas.
In addition to the main sessions, the meeting includes related workshops, Satellite Symposia and Meet-the-Expert Sessions, which deliver further chances to discuss advances and perspectives of basic science and treatment strategies. Additional free contributions will be presented in an oral session (Best of Free Contributions) and as posters. Take the opportunity to present your own data in the context of the poster and the best of free contribution sessions.
Tentative agendas are scheduled to be released in December 2011. Please continue to visit this webpage as well as the official homepage www.acute-leukemias.de to receive updated information.